The recommendations have been sent to the Drugs Controller General of India for final approval. The Ahmedabad-based pharma major had on July 1 applied for emergency use authorization with the Drugs Controller General of India for the vaccine. The company said it has conducted the largest clinical trial for the vaccine in India in over 50 centers so far. If approved, ZyCoViD will be the world’s first D N A vaccine against the novel coronavirus infection, developed by an Indian company and become the sixth vaccine that has been approved for use in the country after Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik V, and the United States made Moderna and Johnson and Johnson.
Daily News, India News, India Podcast, All India Podcast, India News Today
Find out more about us at tatvabodhini.com/about
Follow us: Youtube: https://www.youtube.com/channel/UCOLhD7xOsHFILCW5XBzxvdw Twitter: https://twitter.com/tatvaBodhini_
Instagram: https://www.instagram.com/tatvabodhini/
facebook: https://www.facebook.com/Tatvabodhini
Web: https://tatvabodhini.com.